Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Investor on Agnafit Bidco’s public offer for Sobi
Mandate

Vinge advises Investor on Agnafit Bidco’s public offer for Sobi

September 02, 2021 Capital Markets and Public M&A

Agnafit Bidco has announced a public offer to the shareholders of Swedish Orphan Biovitrum AB (publ).

The total value of the offer is approximately SEK 69.4 billion.

Vinges team mainly includes public M&A partner Erik Sjöman that advises Investor AB (publ), Sobi’s largest shareholder.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026